Form D · Biotechnology
IASO BioMed, Inc.
Centennial, CO · CIK 0001662907
Offering snapshot reported Aug 15, 2017 · SEC filing
- Reported sold
- $100K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jul 20, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2017 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Aug 24, 2016 | Initial | $30,000 | No comparison | 1 | SEC filing |
| Apr 4, 2016 | Initial | $300,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-292844
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Aug 15, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karatzas Costas | Director, Promoter |
| Henry Fong | Promoter |
| Costas Karatazas | Director |
| Costas Kartzas | Director |
| Duane Knight | Executive |
| Keith Mazer | Promoter |
| Vassilios Papadopoulos | Director, Promoter |
| Vassillios Papadopoulos | Director |
| Vasillios Papaodpoulos | Director |
| Richard Schell | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7315 E. Peakview Ave.
Centennial, CO, 80111
Centennial, CO, 80111